Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
460-05-003 ISMRM Abstract

Diffusion-Cognitive Correlates of Cholinergic Pathways Denervation and Glympathic System Activity in Alzheimer Disease

Primary: Neuro - Alzheimer's Disease
Secondary: Diffusion - DWI/DTI/DKI
460-05-003 · When Brain Clearance Fails: Glymphatic Dysfunction Across Disorders · Tuesday, 12 May, 4:00 PM–4:55 PM · Digital Posters Row A
Accepted
Pohchoo Seow 1,2, Septian Hartono1,3, Weiling Lee4, Chuen Chai Seow5, Kang Seng Ting6, Wei Shan Li6, Kok Pin Ng6, Pik Hsien Chai7, Bertwin Chen7, Shi Ni Phua1, Yee Wei Koh7, Yao Chia Shih8, Ling Ling Chan3,9,10
1Singapore General Hospital, Singapore, Singapore
2Duke-NUS Medical School, Singapore, Singapore
3Duke-NUS Medical School, Singapore, Singapore
4Radiography Department, Singapore General Hospital, Singapore General Hospital, Singapore, Singapore
5Singapore General Hospital, Singapore, Singapore
6Department of Neurology, National Neuroscience Institute – SGH Campus, Singapore, Singapore
7Radiography Department, Singapore General Hospital, Singapore, Singapore
8Graduate Institute of Medicine, Yuan Ze University, Taoyuan City, Taiwan, Taiwan
9Department of Neuroradiology, Singapore General Hospital, Singapore, Singapore General Hospital, Singapore, Singapore
10National Neuroscience Institute, Singapore, Singapore
Presenting Author: Pohchoo Seow

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. 1.Bohnen, N. & Albin, R. The cholinergic system in Parkinson’s disease. Behav. Brain Res. 221, 564–573 (2011).
2. 2.Gratwicke, J., Jahanshahi, M. & Foltynie, T. Parkinson’s disease dementia: A neural networks perspective. Brain 138, 1454–1476 (2015).
3. 3.Bohnen et al, Recent Advances in Cholinergic Imaging and Cognitive Decline—Revisiting the Cholinergic Hypothesis of Dementia. Current Geriatrics Reports 2018 Mar;7(1):1-11. doi: 10.1007/s13670-018-0234-4. Epub 2018 Jan 13. [doi]
4. 4.Teipel et al, 2011. The Cholinergic System in Mild Cognitive Impairment and Alzheimer’s Disease: An In Vivo MRI and DTI study. Hum Brain Mapp. 2011 Sep; 32(9): 1349–1362. doi: 10.1002/hbm.21111 [doi]
5. 5.Stage, E., Svaldi, D., Sokolow, S., Risacher, S. L., Marosi, K., Rotter, J. I., ... & Alzheimer's Disease Neuroimaging Initiative. (2021). Prescribing cholinesterase inhibitors in mild cognitive impairment—Observations from the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 7(1), e12168.
6. 6.Hampel, H., Mesulam, M. M., Cuello, A. C., Farlow, M. R., Giacobini, E., Grossberg, G. T., ... & Khachaturian, Z. S. (2018). The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease. Brain, 141(7), 1917-1933.
7. 7.Silva, I., Silva, J., Ferreira, R., & Trigo, D. (2021). Glymphatic system, AQP4, and their implications in Alzheimer’s disease. Neurological research and practice, 3(1), 5.
8. 8.Taoka, T., Masutani, Y., Kawai, H., Nakane, T., Matsuoka, K., Yasuno, F., ... & Naganawa, S. (2017). Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer’s disease cases. Japanese journal of radiology, 35(4), 172-178.
9. 9.Taoka T, Ito R, Nakamichi R, Nakane T, Kawai H, Naganawa S. Diffusion Tensor Image Analysis ALong the Perivascular Space (DTI-ALPS): Revisiting the Meaning and Significance of the Method. Magn Reson Med Sci. Jul 1 2024;23(3):268-290.
10. 10.Huang SY, Zhang YR, Guo Y, et al. Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease. Alzheimers Dement.
11. 11.Chen, C. L., Son, S. J., Schweitzer, N., Jin, H., Li, J., Wang, L., ... & Mayo Clinic Study of Aging. (2025). Periventricular Diffusivity Reflects APOE4-modulated Amyloid Accumulation and Cognitive Impairment in Alzheimer’s Continuum. bioRxiv, 2025-04.
12. 12.Yeh, F. C., Badre, D., & Verstynen, T. (2016). Connectometry: A statistical approach harnessing the analytical potential of the local connectome. Neuroimage, 125, 162-171.
13. 13.Liu, X., Barisano, G., Shao, X., Jann, K., Ringman, J. M., Lu, H., ... & MarkVCID Consortium. (2024). Cross-vendor test-retest validation of diffusion tensor image analysis along the perivascular space (DTI-ALPS) for evaluating glymphatic system function. Aging and disease, 15(4), 1885.
14. 14.Liu, Q., Zhong, M., Yuan, S., Niu, C., & Ma, X. (2021). Clinical study of central cholinergic pathway damage in two mild cognitive impairment patients. Neurological Sciences, 42(11), 4707-4717.
15. 15.Shafiee N et al, (2024). Degeneration in nucleus basalis of Meynert signals earliest stage of Alzheimer’s disease progression. Neurobiol. Aging, 139
16. 16.Crockett, R. A., Casselton, C., Howard, T. M., Wilkins, K. B., Seo, G., Brontë-Stewart, H. M., & Alzheimer's Disease Neuroimaging Initiative. (2024). Lateral thinking: Neurodegeneration of the cortical cholinergic system in Alzheimer's disease. Neurobiology of Disease, 201, 106677.
17. 17.Nemy et al., (2023). Cholinergic white matter pathways along the Alzheirmer’s disease contiunuum. Brain. 146, 5, 2075-2088
18. 18.Engelhardt B, Carare RO, Bechmann I, Flugel A, Laman JD, Weller RO. Vascular, glial, and lymphatic immune gateways of the central nervous system. Acta Neuropathol 2016; 132: 317–38.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/460-05-003